VOR logo

Vor Biopharma (VOR)

Profile

Full Name

Vor Biopharma Inc.

Ticker Symbol

VOR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 5, 2021

Indexes

Not included

Website

http://www.vorbio.com

Employees

159

Key Details

Price

$0.69(-1.29%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.70(+2.86% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.69
VOR price is $0.69

30-Day Relative Volume

0.78
VOR 30-day relative volume is 0.78

Price Performance

Price Most recent change

-1.29%
VOR price was down -1.29% on Apr 14, 2025

Price YTD change

-37.75%
VOR price is down -37.75% since January 1st

Price 1-year change

-61.61%
VOR price is down -61.61% year-on-year

Price 3-year change

-88.19%
VOR price is down -88.19% over the past 3 years

Price Range

Price All-time high

$63.62
VOR price is currently -98.91% below its historical high of $63.62

Price 3-year low

$0.49
VOR price is currently +41.02% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$86.27M
VOR market capitalization is $86.27 million

Market cap 3-year change

-60.5%
VOR market capitalization is down -60.5% over the past 3 years

Market cap All-time high

$2.01B
VOR market capitalization is currently -95.70% below its historical high of $2.01 billion

Market cap sector rank

46.88%
VOR market capitalization is higher than 46.88% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+83.02%
VOR shares outstanding is up +83.02% year-on-year

Shares Outstanding 3-Year Change

+234.4%
VOR shares outstanding is up +234.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.07
VOR beta is 1.07

200-day SMA

$0.96
VOR price is currently -27.89% below its 200-day simple moving average

50-day SMA

$0.99
VOR price is currently -30.50% below its 50-day simple moving average

RSI

41.98
VOR 14-day relative strength index is 41.98

Volume

0.78
VOR 30-day relative volume is 0.78

ATR

$0.08
VOR average true range is $0.08

10-day Historical Volatility

119.69%
VOR 10-day historical volatility is 119.69%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
VOR annual revenue value is unknown

Revenue Analysts estimate

-
VOR annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
VOR annual revenue 1-year change is unknown

Revenue Sector rank

-
VOR annual revenue is unknown

EPS

EPS

-$1.70
VOR annual earnings per share is -$1.70

EPS Analysts estimate

-$0.91
VOR annual earnings per share is currently +87.85% higher than the consensus analysts' forecast

EPS 1-year change

+2.86%
VOR annual earnings per share is up +2.86% year-on-year

EPS Sector rank

41.69%
VOR annual earnings per share is higher than 41.69% of companies in Healthcare sector

Profit

Gross profit

-
VOR annual gross profit value is unknown

Gross margin

-
VOR annual gross profit margin value is unknown

Operating profit

-$121.19M
VOR annual operating income is -$121.19 million

Operating margin

-
VOR annual operating profit margin value is unknown

Net income

-$116.91M
VOR annual net profit is -$116.91 million

Net margin

-
VOR annual net profit margin value is unknown

Expenses

Total expenses

$121.19M
VOR annual total expenses is $121.19 million

Operating expenses

$121.19M
VOR annual total operating expenses is $121.19 million

Cost of goods sold

-
VOR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$27.88M
VOR annual SGA is $27.88 million

Depreciation and amortization

$3.53M
VOR annual depreciation & amortization is $3.53 million

Interest expense

-
VOR annual interest expense value is unknown

Income tax

-
VOR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$121.19M
VOR annual earnings before interest & taxes is -$121.19 million

EBITDA

-$117.66M
VOR annual EBITDA is -$117.66 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$142.89M
VOR annual total assets is $142.89 million

Non current assets

$46.38M
VOR annual long term assets is $46.38 million

Current assets

$96.51M
VOR annual total current assets is $96.51 million

Cash and cash equivalents

$81.95M
VOR annual cash & cash equivalents is $81.95 million

Accounts receivable

-
VOR annual accounts receivable value is unknown

Inventory

-
VOR annual inventory value is unknown

Liabilities

Total liabilities

$46.23M
VOR annual total liabilities is $46.23 million

Long term liabilities

$27.61M
VOR annual total long term liabilities is $27.61 million

Current liabilities

$18.61M
VOR annual total current liabilities is $18.61 million

Accounts payable

$1.50M
VOR annual accounts payable is $1.50 million

Debt

Total debt

$31.83M
VOR annual total debt is $31.83 million

Total debt 1-year change

-10.74%
VOR annual total debt is down -10.74% year-on-year

Long term debt

$27.61M
VOR annual long term debt is $27.61 million

Short term debt

$4.21M
VOR annual short term debt is $4.21 million

Equity & Capital

Shareholders equity

$96.66M
VOR annual stockholders equity is $96.66 million

Book value

$96.66M
VOR annual book value is $96.66 million

Retained earnings

-$456.99M
VOR annual retained earnings is -$456.99 million

Working capital

$77.89M
VOR annual working capital is $77.89 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$99.66M
VOR annual cash flow from operations is -$99.66 million

Cash from operations 1-year change

+0.63%
VOR annual cash flow from operations is up +0.63% year-on-year

Cash from investing

$96.86M
VOR annual cash flow from investing activities is $96.86 million

Cash from investing 1-year change

+36.4%
VOR annual cash flow from investing activities is up +36.4% year-on-year

Cash from financing

$53.39M
VOR annual cash flow from financing activities is $53.39 million

Cash from financing 1-year change

+1717.29%
VOR annual cash flow from financing activities is up +1717.29% year-on-year

CAPEX

CAPEX

-
VOR annual capital expenditures value is unknown

CAPEX 1-year change

-
VOR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$99.89M
VOR annual free cash flow is -$99.89 million

Free cash flow 1-year change

+1.45%
VOR annual free cash flow is up +1.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
VOR annual gross profit margin value is unknown

Operating margin

-
VOR annual operating profit margin value is unknown

Net margin

-
VOR annual net profit margin value is unknown

ROA & ROE

ROA

-81.82%
VOR annual return on assets is -81.82%

ROE

-120.95%
VOR annual return on equity is -120.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VOR price to earnings ratio value is unknown

PE ratio Sector rank

-
VOR price to earnings ratio is unknown

PB Ratio

PB ratio

0.89
VOR price to book ratio is 0.89

PB ratio Sector rank

41.81%
VOR price to book ratio is higher than 41.81% of companies in Healthcare sector

PS Ratio

PS ratio

-
VOR price to sales ratio value is unknown

PS ratio Sector rank

-
VOR price to sales ratio is unknown

Enterprise value

Enterprise value

$36.15M
VOR enterprise value is $36.15 million

Enterprise value Sector rank

37.6%
VOR enterprise value is higher than 37.6% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.31
VOR EV/EBITDA is -0.31

EV/EBITDA Sector rank

55.91%
VOR EV/EBITDA is higher than 55.91% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.19
VOR annual current ratio is 5.19

Quick ratio

-
VOR annual quick ratio value is unknown

Leverage

Debt to equity

0.33
VOR annual debt to equity ratio is 0.33

Interest coverage ratio

-
VOR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
VOR piotroski f-score value is unknown

Altman Z-Score

-
VOR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 21, 25 Stifel
Buy
Mar 21, 25 Oppenheimer
Outperform
Mar 21, 25 HC Wainwright & Co.
Buy
Dec 10, 24 JMP Securities
Market Outperform
Dec 10, 24 HC Wainwright & Co.
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Baird
Outperform
Sep 6, 24 JMP Securities
Market Outperform
Sep 6, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Barclays
Overweight

Institutional Ownership

Similar stocks

PLRX logo
Pliant Therapeutics (PLRX)
ANIX logo
Anixa Biosciences (ANIX)
SNTI logo
Senti Biosciences (SNTI)
CCCC logo
C4 Therapeutics (CCCC)
CRDL logo
Cardiol Therapeutics (CRDL)
ZNTL logo
Zentalis Pharmaceuticals (ZNTL)
GALT logo
Galectin Therapeutics (GALT)
IMUX logo
Immunic (IMUX)
CRVO logo
CervoMed (CRVO)
  • What is the ticker symbol for Vor Biopharma?
  • Does Vor Biopharma pay dividends?
  • What sector is Vor Biopharma in?
  • What industry is Vor Biopharma in?
  • What country is Vor Biopharma based in?
  • When did Vor Biopharma go public?
  • Is Vor Biopharma in the S&P 500?
  • Is Vor Biopharma in the NASDAQ 100?
  • Is Vor Biopharma in the Dow Jones?
  • When was Vor Biopharma's last earnings report?
  • When does Vor Biopharma report earnings?
  • Should I buy Vor Biopharma stock now?

What is the ticker symbol for Vor Biopharma?

The ticker symbol for Vor Biopharma is NASDAQ:VOR

Does Vor Biopharma pay dividends?

No, Vor Biopharma does not pay dividends

What sector is Vor Biopharma in?

Vor Biopharma is in the Healthcare sector

What industry is Vor Biopharma in?

Vor Biopharma is in the Biotechnology industry

What country is Vor Biopharma based in?

Vor Biopharma is headquartered in United States

When did Vor Biopharma go public?

Vor Biopharma's initial public offering (IPO) was on February 5, 2021

Is Vor Biopharma in the S&P 500?

No, Vor Biopharma is not included in the S&P 500 index

Is Vor Biopharma in the NASDAQ 100?

No, Vor Biopharma is not included in the NASDAQ 100 index

Is Vor Biopharma in the Dow Jones?

No, Vor Biopharma is not included in the Dow Jones index

When was Vor Biopharma's last earnings report?

Vor Biopharma's most recent earnings report was on Mar 20, 2025

When does Vor Biopharma report earnings?

The next expected earnings date for Vor Biopharma is May 9, 2025

Should I buy Vor Biopharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page